Original disclosure @ IFC website
Updated in EWS Feb 5, 2023
Disclosed by Bank Apr 30, 2022
Can you contribute information about this project?
Contact the EWS Team
According to the Bank’s website, the proposed investment is a finance package of up to US$48.6 million comprised of: (i) approximately US$28.6 million of equity; and (ii) approximately US$20 million of secured ‘A’ Loan into Avacare Global, an integrated distributor and manufacturer of pharmaceutical and healthcare consumable products in Sub-Saharan Africa.
The investment provides patient capital and long-term financing to support the growth aspirations of the Company.
|Private Actor 1||Private Actor 1 Role||Private Actor 1 Sector||Relation||Private Actor 2||Private Actor 2 Role||Private Actor 2 Sector|
Chief Executive Officer
+27 84 500 0080
ACCESS TO INFORMATION
You can submit a request for information disclosure at: https://disclosures.ifc.org/#/inquiries
If you believe that your request for information from IFC has been unreasonably denied, or that this Policy has been interpreted incorrectly, you can submit a complaint at the link above to IFC's Access to Information Policy Advisor, who reports directly to IFC's Executive Vice President.
ACCOUNTABILITY MECHANISM OF IFC/MIGA
The Compliance Advisor Ombudsman (CAO) is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an IFC or MIGA- financed project. If you submit a complaint to the CAO, they may assist you in resolving a dispute with the company and/or investigate to assess whether the IFC is following its own policies and procedures for preventing harm to people or the environment. If you want to submit a complaint electronically, you can email the CAO at CAO@worldbankgroup.org You can learn more about the CAO and how to file a complaint at http://www.cao-ombudsman.org